Drinkable gene therapy foam for the treatment of constrictive esophageal carcinoma
info@genetherapynet.com (Administrator)
Posted on: 16 February 2026, source: Nature Patients with esophageal cancer (EC) face intensive treatments with limited success and severe side effects, including severe swallowing difficulties. A novel drinkable gene therapy foam coats the esophagus and delivers mRNA treatment directly to the tumor site. In laboratory models, it achieved 110-fold greater tumor regression than standard treatment and enhanced the effects of radiotherapy. This easy-to-administer therapy could help patients maintai